NanoGroup S.A. (WSE:NNG)

Market Cap	84.86M -14.0%
Revenue (ttm)	-6.90K +4.0%
Net Income	-6.93M
EPS	-0.19
Shares Out	32.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	458,756
Average Volume	68,373
Open	2.585
Previous Close	2.585
Day's Range	2.465 - 2.650
52-Week Range	2.250 - 3.620
Beta	0.64
RSI	61.39
Earnings Date	Apr 23, 2026

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology. The company was founded in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.